CNS Pharmaceuticals, Inc. (CNSP) vs Enveric Biosciences, Inc. (ENVB)

A side-by-side comparison of CNS Pharmaceuticals, Inc. and Enveric Biosciences, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare
CNS Pharmaceuticals, Inc. logo
CNSP
CNS Pharmaceuticals, Inc.
$8M
$5.31HealthcareDelayed quote: Oct 6, 2026, 3:28 PM EDT
Enveric Biosciences, Inc. logo
ENVB
Enveric Biosciences, Inc.
$7M
$1.49HealthcareDelayed quote: Oct 6, 2026, 3:24 PM EDT

Total return — CNSP vs ENVB

growth of $100 · dividends reinvested · last 7y
CNSP -100.0% (-85.1%/yr)ENVB -100.0% (-76.1%/yr)ENVB compounded faster over this window
Log scale — wide-divergence pair
000001101001kStart $100202120232025$0$0
CNSP ENVB

CNSP vs ENVB: by the numbers

  • •CNSP is the larger company ($8M vs $7M market cap).

Metrics side by side

Valuation

MetricCNSPENVB
P/B ratio0.430.82

Profitability

MetricCNSPENVB
Gross margin0.00%0.00%
Operating margin0.00%0.00%
Net margin0.00%0.00%
ROE-91.75%-108.00%
ROIC-92.94%-107.99%

Growth (annualized)

MetricCNSPENVB
Total return CAGR (5Y)-91.63%N/A

Go deeper

Full CNSP analysisFull ENVB analysisInteractive comparison tool

Dig into the metrics

CNS Pharmaceuticals ROEEnveric Biosciences ROECNS Pharmaceuticals operating marginEnveric Biosciences operating marginCNS Pharmaceuticals revenue growthEnveric Biosciences revenue growthCNS Pharmaceuticals free cash flowEnveric Biosciences free cash flow

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.